Rachel's Remedies Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $5K
Latest Deal Amount
  • Investors
  • 3

Rachel's Remedies General Information

Description

Developer of moist heat therapy for breastfeeding mothers. The company develops moist heat therapy for hands-free relief. Through the therapy breastfeeding conditions and pain is relieved.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 2316 Delaware Avenue
  • Suite 174
  • Buffalo, NY 14216
  • United States
+1 (716) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rachel's Remedies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 21-Oct-2016 $5K Completed Startup
2. Grant 16-Mar-2016 0000 Completed Startup
1. Accelerator/Incubator 18-Sep-2015 Completed Startup
To view Rachel's Remedies’s complete valuation and funding history, request access »

Rachel's Remedies Patents

Rachel's Remedies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10426657-B2 Thermal device for treating breastfeeding conditions Active 03-Oct-2014 00000000
US-20160095743-A1 Thermal device for treating breastfeeding conditions Granted 03-Oct-2014 00000000 0

Rachel's Remedies Executive Team (1)

Name Title Board Seat Contact Info
Rachel Jackson Founder, President and Chief Executive Officer
To view Rachel's Remedies’s complete executive team members history, request access »

Rachel's Remedies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
43North Accelerator/Incubator 000 0000 000000 0
Launch NY Venture Capital Minority 000 0000 000000 0
Z80 Labs Accelerator/Incubator 000 0000 000000 0
To view Rachel's Remedies’s complete investors history, request access »